- Home
- ABR vs PSNL Comparison
ABR vs PSNL Comparison
Compare ABR & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABR | PSNL |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2003 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ABR | PSNL |
|---|---|---|
| Price | $4.98 | $13.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $9.90 | ★ $12.20 |
| AVG Volume (30 Days) | ★ 3.9M | 3.2M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | ★ 15.42% | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,648,000.00 |
| Revenue This Year | N/A | $15.34 |
| Revenue Next Year | N/A | $41.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.73 | $4.45 |
| 52 Week High | $12.58 | $16.39 |
Technical Indicators
Market Signals| Indicator | ABR | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 44.16 | 57.08 |
| Support Level | $4.99 | $6.89 |
| Resistance Level | $5.43 | $14.81 |
| Average True Range (ATR) | 0.19 | 0.59 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 40.67 | 79.03 |
Price Performance
Historical ComparisonAbout ABR Arbor Realty Trust
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.